603392 萬泰生物
按盤價 
72.160 -1.590 (-2.156%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.123 | 9.965 | 56.353 | 57.592 | 32.924 |
| 總資產報酬率 ROA (%) | 1.751 | 7.812 | 40.693 | 38.323 | 23.886 |
| 投入資產回報率 ROIC (%) | 2.056 | 9.626 | 53.875 | 53.908 | 31.843 | 邊際利潤分析 |
| 銷售毛利率 (%) | 71.828 | 85.626 | 89.536 | 85.780 | 81.219 |
| 營業利潤率 (%) | 13.576 | 25.431 | 50.031 | 40.493 | 32.928 |
| 息稅前利潤/營業總收入 (%) | 10.489 | 23.598 | 49.361 | 40.508 | 32.954 |
| 淨利潤/營業總收入 (%) | 13.885 | 22.619 | 43.480 | 36.158 | 28.961 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 7.772 | 117.129 | 97.395 | 100.950 | 100.280 |
| 價值變動淨收益/利潤總額(%) | 43.384 | 8.867 | 0.826 | 0.484 | 1.825 |
| 營業外收支淨額/利潤總額(%) | -7.443 | -0.578 | -0.239 | -0.185 | -1.406 | 償債能力分析 |
| 流動比率 (X) | 4.611 | 3.858 | 3.495 | 1.964 | 2.386 |
| 速動比率 (X) | 4.177 | 3.519 | 3.245 | 1.713 | 1.903 |
| 資產負債率 (%) | 14.451 | 18.017 | 22.580 | 35.247 | 26.352 |
| 帶息債務/全部投入資本 (%) | 2.373 | 3.215 | 2.628 | 5.144 | 0.910 |
| 股東權益/帶息債務 (%) | 4,100.093 | 2,999.358 | 3,682.842 | 1,798.492 | 10,500.828 |
| 股東權益/負債合計 (%) | 583.244 | 448.572 | 336.767 | 179.842 | 276.584 |
| 利息保障倍數 (X) | -4.887 | -13.986 | -89.610 | 448.350 | 68.254 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 376.780 | 226.370 | 99.701 | 92.256 | 72.086 |
| 存貨周轉天數 (天) | 430.890 | 403.260 | 224.891 | 218.631 | 259.113 |
| 備註： | 即時報價更新時間為 15/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
